CVS Health Total Liabilities 2010-2025 | CVS
CVS Health total liabilities from 2010 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
- CVS Health total liabilities for the quarter ending March 31, 2025 were $178.475B, a 1.64% increase year-over-year.
- CVS Health total liabilities for 2024 were $177.485B, a 2.54% increase from 2023.
- CVS Health total liabilities for 2023 were $173.092B, a 10.6% increase from 2022.
- CVS Health total liabilities for 2022 were $156.506B, a 0.71% decline from 2021.
| CVS Health Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $177,485 |
| 2023 | $173,092 |
| 2022 | $156,506 |
| 2021 | $157,618 |
| 2020 | $161,014 |
| 2019 | $158,279 |
| 2018 | $137,913 |
| 2017 | $57,436 |
| 2016 | $57,628 |
| 2015 | $55,234 |
| 2014 | $36,224 |
| 2013 | $33,588 |
| 2012 | $28,568 |
| 2011 | $26,492 |
| 2010 | $24,469 |
| 2009 | $25,873 |
| CVS Health Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2025-03-31 | $178,475 |
| 2024-12-31 | $177,485 |
| 2024-09-30 | $177,321 |
| 2024-06-30 | $177,370 |
| 2024-03-31 | $175,593 |
| 2023-12-31 | $173,092 |
| 2023-09-30 | $176,796 |
| 2023-06-30 | $177,069 |
| 2023-03-31 | $167,750 |
| 2022-12-31 | $156,506 |
| 2022-09-30 | $160,201 |
| 2022-06-30 | $154,773 |
| 2022-03-31 | $158,733 |
| 2021-12-31 | $157,618 |
| 2021-09-30 | $160,273 |
| 2021-06-30 | $157,599 |
| 2021-03-31 | $158,442 |
| 2020-12-31 | $161,014 |
| 2020-09-30 | $163,786 |
| 2020-06-30 | $167,140 |
| 2020-03-31 | $165,165 |
| 2019-12-31 | $158,279 |
| 2019-09-30 | $157,180 |
| 2019-06-30 | $157,305 |
| 2019-03-31 | $159,762 |
| 2018-12-31 | $137,913 |
| 2018-09-30 | $94,884 |
| 2018-06-30 | $97,679 |
| 2018-03-31 | $96,462 |
| 2017-12-31 | $57,436 |
| 2017-09-30 | $57,985 |
| 2017-06-30 | $58,378 |
| 2017-03-31 | $58,828 |
| 2016-12-31 | $57,628 |
| 2016-09-30 | $58,202 |
| 2016-06-30 | $57,982 |
| 2016-03-31 | $56,603 |
| 2015-12-31 | $55,234 |
| 2015-09-30 | $55,182 |
| 2015-06-30 | $37,535 |
| 2015-03-31 | $36,935 |
| 2014-12-31 | $36,224 |
| 2014-09-30 | $35,467 |
| 2014-06-30 | $34,461 |
| 2014-03-31 | $34,610 |
| 2013-12-31 | $33,588 |
| 2013-09-30 | $29,271 |
| 2013-06-30 | $27,378 |
| 2013-03-31 | $27,859 |
| 2012-12-31 | $28,568 |
| 2012-09-30 | $27,880 |
| 2012-06-30 | $27,676 |
| 2012-03-31 | $27,953 |
| 2011-12-31 | $26,492 |
| 2011-09-30 | $27,764 |
| 2011-06-30 | $27,243 |
| 2011-03-31 | $24,909 |
| 2010-12-31 | $24,469 |
| 2010-09-30 | $25,076 |
| 2010-06-30 | $25,652 |
| 2010-03-31 | $25,590 |
| 2009-12-31 | $25,873 |
| 2009-09-30 | $26,204 |
| 2009-06-30 | $24,884 |
| 2009-03-31 | $25,367 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $85.490B | $372.809B |
| CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $141.323B | 26.51 |
| Elevance Health (ELV) | United States | $85.046B | 10.97 |
| Cencora (COR) | United States | $57.007B | 19.83 |
| Natera (NTRA) | United States | $23.468B | 0.00 |
| DiDi Global (DIDIY) | China | $23.015B | 24.45 |
| Labcorp Holdings (LH) | United States | $21.974B | 17.82 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.262B | 0.00 |
| Solventum (SOLV) | United States | $12.973B | 13.73 |
| CochLear (CHEOY) | Australia | $12.633B | 0.00 |
| ICON (ICLR) | Ireland | $11.996B | 11.15 |
| Revvity (RVTY) | United States | $11.361B | 19.55 |
| Viatris (VTRS) | United States | $10.504B | 3.61 |
| Avantor (AVTR) | United States | $9.172B | 13.33 |
| Medpace Holdings (MEDP) | United States | $9.062B | 24.07 |
| HealthEquity (HQY) | United States | $9.009B | 39.46 |
| Sonic Healthcare (SKHHY) | Australia | $8.263B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.289B | 14.28 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.259B | 25.08 |
| BrightSpring Health Services (BTSG) | United States | $4.024B | 36.92 |
| Sotera Health (SHC) | United States | $3.191B | 18.13 |
| Alignment Healthcare (ALHC) | United States | $2.786B | 0.00 |
| Concentras Parent (CON) | United States | $2.716B | 15.70 |
| Surgery Partners (SGRY) | United States | $2.705B | 35.18 |
| GeneDx Holdings (WGS) | United States | $2.594B | 99.89 |
| Organon (OGN) | United States | $2.587B | 2.75 |
| PACS (PACS) | United States | $1.928B | 0.00 |
| Ardent Health (ARDT) | United States | $1.887B | 8.04 |
| Progyny (PGNY) | United States | $1.822B | 40.11 |
| GoodRx Holdings (GDRX) | United States | $1.811B | 36.21 |
| Premier (PINC) | United States | $1.791B | 13.59 |
| Teladoc Health (TDOC) | United States | $1.403B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.158B | 8.81 |
| CareDx (CDNA) | United States | $1.051B | 16.42 |
| Establishment Labs Holdings (ESTA) | $1.034B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.999B | 0.00 |
| Agilon Health (AGL) | United States | $0.915B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.840B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.831B | 7.78 |
| Nutex Health (NUTX) | United States | $0.641B | 9.70 |
| LifeMD (LFMD) | United States | $0.639B | 0.00 |
| Embecta (EMBC) | United States | $0.597B | 4.02 |
| InnovAge Holding (INNV) | United States | $0.545B | 0.00 |
| Enhabit (EHAB) | United States | $0.482B | 39.62 |
| Sonida Senior Living (SNDA) | United States | $0.463B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.463B | 10.42 |
| SBC Medicals (SBC) | United States | $0.442B | 0.00 |
| Omada Health (OMDA) | $0.404B | 0.00 | |
| Performant Healthcare (PHLT) | United States | $0.298B | 0.00 |
| Beauty Health (SKIN) | United States | $0.242B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.237B | 0.00 |
| Oncology Institute (TOI) | United States | $0.210B | 0.00 |
| DocGo (DCGO) | United States | $0.176B | 28.83 |
| So-Young (SY) | China | $0.174B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.123B | 0.00 |
| OncoCyte (IMDX) | United States | $0.099B | 0.00 |
| KindlyMD (NAKA) | United States | $0.092B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.076B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.055B | 0.00 |
| ModivCare (MODV) | United States | $0.046B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.041B | 0.00 |
| Biodesix (BDSX) | United States | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |